Michael D. Taylor, Ph.D.« Back
Michael D. Taylor, Ph.D. served as President and CEO of Deciphera Pharmaceuticals from 2014 until 2019. He is an Operating Partner with Mission BioCapital, an early-stage life science venture fund. Prior to joining Deciphera, Dr. Taylor was Chief Executive Officer of Ensemble Therapeutics, Corp., a small molecule drug discovery company, from July 2007 to October 2013. Prior to joining Ensemble, Dr. Taylor was Senior Vice President for Pfizer Inc.’s Global R&D division and served as Vice President, Drug Development at Warner-Lambert/Parke-Davis, where he led early and late-stage development projects across multiple therapeutic areas, including Lipitor® and Neurontin®. Dr. Taylor has authored or coauthored 65 manuscripts and published abstracts and is co-inventor on eight patents. Dr. Taylor holds a Ph.D. in Medicinal Chemistry from the State University of New York at Buffalo School of Pharmacy, was awarded a NIH postdoctoral fellowship in natural products synthesis and structure elucidation at the University of Pennsylvania and holds B.S. magna cum laude in chemistry from the University of South Florida.